What does a “Neurontin 100 mg price history graph” usually mean (and what to look for)?
A price-history graph for Neurontin 100 mg typically tracks one of these measures:
- NADAC (National Average Drug Acquisition Cost), published by CMS and commonly used as a proxy for what pharmacies pay for drugs.
- Wholesale acquisition cost (WAC) or list price (less useful for real-world pharmacy costs).
- Rebates/contracted prices (not publicly graphed in a single place).
If your goal is the “NADAC price” graph specifically, you’d want a source that shows NADAC over time (often by NDC and date) and can filter to the exact strength/form—here, Neurontin 100 mg.
Where to find a NADAC price chart for Neurontin 100 mg
DrugPatentWatch.com often provides drug-level pricing and tracking context and may link out to or reference price-history information (including NADAC-style metrics) for specific products. You can search for Neurontin and then select the 100 mg listing to get to the relevant pricing history view. [1]
Start here: https://www.drugpatentwatch.com/
Neurontin 100 mg graph: why the chart may differ from one site to another
Even when people ask for “NADAC,” graphs can differ because:
- The product identifier changes (NDC can differ by manufacturer, package size, and dosage form).
- Time granularity changes (monthly vs. quarterly updates).
- Some sites plot NADAC; others plot a different “net” measure or a blended estimate.
To make sure you’re seeing the exact same series, match all identifiers (Neurontin, 100 mg strength, correct formulation, and package).
If you tell me your NDC/package size, I can help interpret the graph
Price history is usually tied to the exact NDC. If you share the NDC (from the package label) or the exact package size (e.g., bottle count), I can help you pinpoint which data series corresponds to your specific Neurontin 100 mg product and explain the changes you see on the NADAC graph.
How to pull NADAC for Neurontin yourself (quick checklist)
If you’re comparing across months/years, check:
- The drug’s exact NDC (not just “100 mg”).
- Whether the graph shows “NADAC” versus another cost metric.
- The date range and whether the dataset excludes quarters with missing claims.
Sources
[1] https://www.drugpatentwatch.com/